ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Common Stock Issued

Cash raised by issuing new shares.

No reported Common Stock Issued figures are available to summarize.

Common Stock Issued history

Currency unavailable · from the cash flow

No Common Stock Issued data reported for this period type.

Common Stock Issued vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Common Stock Issued for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$486.47M USD+117.8%+110.5%677.6%
STOKStoke Therapeutics, Inc.LTM Mar 2026$180.34M USD+39.9%+29.0%562.2%
BNTCBenitec Biopharma Inc.LTM Mar 2026$107.05M USD-1.8%——
MGTXMeiraGTx Holdings plcLTM Mar 2026$24.86M USD-60.1%-15.0%31.2%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$12.44M USD—+219.3%27.4%
PRMEPrime Medicine, Inc.LTM Mar 2026$393K USD-99.8%-9.0%9.7%
PRQRProQR Therapeutics N.V.LTM Mar 2026€1.71K EUR—-83.3%0.0%
SLNSilence Therapeutics plcLTM Mar 2026$911.01 USD—-93.4%0.1%
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-1.8%-9.0%18.6%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.